Download PDF
J Neurol Surg A Cent Eur Neurosurg 2018; 79(03): 268-272
DOI: 10.1055/s-0037-1608869
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Optic Nerve Glioma in Two Sisters with Family History of Neurofibromatosis Type 1

Jivko Kolev Surchev
1   Department of Neurosurgery, UMHAT “St. Ivan Rilski”, Medical University, Sofia, Bulgaria
,
Sevdalin Nachev
2   Department of General and Clinical Pathology, MMA, Sofia, Bulgaria
,
Lyudmila Pavlova Todorova
3   Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Sofia, Bulgaria
,
Marin Marinov
1   Department of Neurosurgery, UMHAT “St. Ivan Rilski”, Medical University, Sofia, Bulgaria
› Author Affiliations
Further Information

Publication History

17 March 2017

24 August 2017

Publication Date:
02 January 2018 (online)

    Permissions and Reprints

Abstract

Optic nerve glioma (ONG) is associated in 10% of patients with neurofibromatosis (NF) type 1. To date no consensus has been reached regarding the therapeutic approach and prevention of visual impairment in these patients. Reports in the literature vary from a conservative approach (observation) to the use of single treatment modalities or multimodality protocols of surgical removal, radiotherapy, and/or chemotherapy. We present our experience with two siblings with ONG whose mother carries cutaneous stigmata of NF type 1. The younger sister was diagnosed 3 years after the treatment of the older sibling following recommended imaging for screening. Postoperative follow-up for 11 and 15 years, respectively, demonstrated lack of tumor regrowth and preserved vision in the contralateral eye. We discuss the treatment strategy in pediatric patients with orbital ONG associated with NF type 1.

Keywords

optic nerve glioma - von Recklinghausen disease - heredity

Note

We had the informed consent of the mother and the children to publish the cases accompanied by photographs.


 

  • References

  • 1 Lindegaard J, Heegaard S. Tumors of the optic nerve. Expert Rev Ophthalmol 2009; 4 (02) 197-206
    CrossrefPubMedGoogle Scholar
  • 2 Johansen S, Heegaard S, Bøgeskov L, Prause JU. Orbital space-occupying lesions in Denmark 1974–1997. Acta Ophthalmol Scand 2000; 78 (05) 547-552
    CrossrefPubMedGoogle Scholar
  • 3 Hollander MD, FitzPatrick M, O'Connor SG, Flanders AE, Tartaglino LM. Optic gliomas. Radiol Clin North Am 1999; 37 (01) 59-71 , ix
    CrossrefPubMedGoogle Scholar
  • 4 Beres SJ, Avery RA. Optic pathway gliomas. J Pediatr Neurol 2017; 15 (01) 15-24
    PubMedGoogle Scholar
  • 5 Cameron J, Rodriguez F, Rushing E, Horkayne-Szakaly I, Eberhart C. An 80-year experience with optic nerve glioma cases at the Armed Forces Institute of Pathology: evolution from museum to molecular evaluation suggests possible interventions in the cellular senescence and microglial pathways (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 2014; 112: 11-25
    PubMedGoogle Scholar
  • 6 Revere KE, Katowitz WR, Katowitz JA, Rorke-Adams L, Fisher MJ, Liu GT. Childhood optic nerve glioma: vision loss due to biopsy. Ophthal Plast Reconstr Surg 2017; 33 (3S, Suppl 1): S107-S109
    CrossrefPubMedGoogle Scholar
  • 7 Blazo MA, Lewis RA, Chintagumpala MM, Frazier M, McCluggage C, Plon SE. Outcomes of systematic screening for optic pathway tumors in children with neurofibromatosis type 1. Am J Med Genet A 2004; 127A (03) 224-229
    CrossrefPubMedGoogle Scholar
  • 8 Fried I, Tabori U, Tihan T, Reginald A, Bouffet E. Optic pathway gliomas: a review. CNS Oncol 2013; 2 (02) 143-159
    CrossrefPubMedGoogle Scholar
  • 9 Falsini B, Chiaretti A, Rizzo D. , et al. Nerve growth factor improves visual loss in childhood optic gliomas: a randomized, double-blind, phase II clinical trial. Brain 2016; 139 (Pt 2): 404-414
    CrossrefPubMedGoogle Scholar
  • 10 Goodden J, Pizer B, Pettorini B. , et al. The role of surgery in optic pathway/hypothalamic gliomas in children. J Neurosurg Pediatr 2014; 13 (01) 1-12
    CrossrefPubMedGoogle Scholar
  • 11 Valdueza JM, Lohmann F, Dammann O, Hagel C, Eckert B, Freckmann N. Analysis of 20 primarily surgically treated chiasmatic/hypothalamic pilocytic astrocytomas. Acta Neurochir (Wien) 1994; 126 (01) 44-50
    CrossrefPubMedGoogle Scholar
  • 12 Zeid JL, Charrow J, Sandu M, Goldman S, Listernick R. Orbital optic nerve gliomas in children with neurofibromatosis type 1. J AAPOS 2006; 10 (06) 534-539
    CrossrefPubMedGoogle Scholar
  • 13 Binning MJ, Liu JK, Kestle JR, Brockmeyer DL, Walker ML. Optic pathway gliomas: a review. Neurosurg Focus 2007; 23 (05) E2
    PubMedGoogle Scholar
  • 14 Bowers DC, Mulne AF, Reisch JS. , et al. Nonperioperative strokes in children with central nervous system tumors. Cancer 2002; 94 (04) 1094-1101
    CrossrefPubMedGoogle Scholar
  • 15 Bowers DC, Liu Y, Leisenring W. , et al. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2006; 24 (33) 5277-5282
    CrossrefPubMedGoogle Scholar
  • 16 Inskip PD, Curtis RE. New malignancies following childhood cancer in the United States, 1973–2002. Int J Cancer 2007; 121 (10) 2233-2240
    CrossrefPubMedGoogle Scholar
  • 17 Fisher MJ, Loguidice M, Gutmann DH. , et al. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro-oncol 2012; 14 (06) 790-797
    CrossrefPubMedGoogle Scholar
  • 18 El Beltagy MA, Reda M, Enayet A. , et al. Treatment and outcome in 65 children with optic pathway gliomas. World Neurosurg 2016; 89: 525-534
    CrossrefPubMedGoogle Scholar
  • 19 Ater JL, Zhou T, Holmes E. , et al. Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group. J Clin Oncol 2012; 30 (21) 2641-2647
    CrossrefPubMedGoogle Scholar
  • 20 Massimino M, Spreafico F, Cefalo G. , et al. High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol 2002; 20 (20) 4209-4216
    CrossrefPubMedGoogle Scholar
  • 21 Le Deley MC, Leblanc T, Shamsaldin A. , et al; Société Française d'Oncologie Pédiatrique. Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie Pédiatrique. J Clin Oncol 2003; 21 (06) 1074-1081
    CrossrefPubMedGoogle Scholar
  • 22 Opocher E, Kremer LC, Da Dalt L. , et al. Prognostic factors for progression of childhood optic pathway glioma: a systematic review. Eur J Cancer 2006; 42 (12) 1807-1816
    CrossrefPubMedGoogle Scholar
  • 23 Jenkin D, Angyalfi S, Becker L. , et al. Optic glioma in children: surveillance, resection, or irradiation?. Int J Radiat Oncol Biol Phys 1993; 25 (02) 215-225
    CrossrefPubMedGoogle Scholar
  • 24 Jahraus CD, Tarbell NJ. Optic pathway gliomas. Pediatr Blood Cancer 2006; 46 (05) 586-596
    PubMedGoogle Scholar
  • 25 Fisher PG, Tihan T, Goldthwaite PT. , et al. Outcome analysis of childhood low-grade astrocytomas. Pediatr Blood Cancer 2008; 51 (02) 245-250
    CrossrefPubMedGoogle Scholar
  • 26 Merchant TE, Kun LE, Wu S, Xiong X, Sanford RA, Boop FA. Phase II trial of conformal radiation therapy for pediatric low-grade glioma. J Clin Oncol 2009; 27 (22) 3598-3604
    CrossrefPubMedGoogle Scholar
  • 27 Tao ML, Barnes PD, Billett AL. , et al. Childhood optic chiasm gliomas: radiographic response following radiotherapy and long-term clinical outcome. Int J Radiat Oncol Biol Phys 1997; 39 (03) 579-587
    CrossrefPubMedGoogle Scholar
  • 28 Liu GT. Optic gliomas of the anterior visual pathway. Curr Opin Ophthalmol 2006; 17 (05) 427-431
    CrossrefPubMedGoogle Scholar
  • 29 Shriver EM, Ragheb J, Tse DT. Combined transcranial-orbital approach for resection of optic nerve gliomas: a clinical and anatomical study. Ophthal Plast Reconstr Surg 2012; 28 (03) 184-191
    CrossrefPubMedGoogle Scholar
  • 30 Avery RA, Ferner RE, Listernick R, Fisher MJ, Gutmann DH, Liu GT. Visual acuity in children with low grade gliomas of the visual pathway: implications for patient care and clinical research. J Neurooncol 2012; 110 (01) 1-7
    CrossrefPubMedGoogle Scholar